Preclinical characterization and clinical translation of pharmacodynamic markers for MK-5890: a human CD27 activating antibody for cancer immunotherapy

Lars Guelen; Thierry O Fischmann; Jerelyn Wong; Smita Mauze; Marco Guadagnoli; Nikolina Bąbała; Jozef Wagenaars; Veronica Juan; David Rosen; Winnie Prosise; Maurice Habraken; Imke Lodewijks; Danling Gu; Judith Stammen-Vogelzangs; Ying Yu; Jeanne Baker; David Lutje Hulsik; Lilian Driessen-Engels; Dan Malashock; Joost Kreijtz; Astrid Bertens; Evert de Vries; Astrid Bovens; Arne Bramer; Yiwei Zhang; Richard Wnek; Sean Troth; Elliot Chartash; Konstantin Dobrenkov; Svetlana Sadekova; Andrea van Elsas; Jason K Cheung; Laurence Fayadat-Dilman; Jannie Borst; Amy M Beebe; Hans Van Eenennaam

doi:10.1136/jitc-2022-005049

Citation Tools

PDF

PDF +
Supplementary
Material

Clinical/translational cancer immunotherapy

Original research

Preclinical characterization and clinical translation of pharmacodynamic markers for MK-5890: a human CD27 activating antibody for cancer immunotherapy

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Cite this article as:: Guelen L, Fischmann TO, Wong J, et al

Preclinical characterization and clinical translation of pharmacodynamic markers for MK-5890: a human CD27 activating antibody for cancer immunotherapy

Journal for ImmunoTherapy of Cancer 2022;10:e005049. doi: 10.1136/jitc-2022-005049

Log in using your username and password

Main menu

Log in using your username and password

You are here

Download to a citation manager

Read the full text or download the PDF:

Log in using your username and password